Quinacrine (Supplementary Fig. S1B and C) and thimerosal (Supplementary Fig. S1D and E) inhibited SN-38-induced TopBP1 focus formation also in the prostate cancer cell line LNCaP. Here, TOPBP1 is linked to prostate carcinoma.